Novartis, stressing Beovu safety, matches Eylea in head-to-head diabetic macular edema trial aliu Mon, 09/14/2020 – 11:16

Pharma scores modest boost in annual image poll, hands last place back to the feds bbulik Mon, 09/14/2020 […]

Research project developed by TU Berlin and the University of Luxembourg receives funding of 125,000 US dollars from […]

The UNC School of Medicine lab of Camille Ehre, PhD, generated high-powered microscopic images showing startlingly high SARS-CoV-2 […]

“Our Shetland health improvement officer Joanna Inkster told us about ‘deskercise’—exercises we could do at work developed by […]

Under the deal the UK and Japan will incorporate functions of the existing EU/Japan Mutual Recognition Agreement for […]

The move adds Trodelvy, a first-in-class antibody-drug conjugate approved to treat triple-negative breast cancer, to the drugmaker’s portfolio

The move follows a green light by the UK’s MHRA

The Institute has endorsed the drug for first-line treatment of adults with locally-advanced or EGFR mutation-positive NSCLC

Updated Date: Fri, 04 Sep 2020 00:00:00 EDT